CTIM-10. PHASE II STUDY OF PEMBROLIZUMAB PLUS SurVaxM FOR GLIOBLASTOMA AT FIRST RECURRENCE

Added 561 days ago (10.11.2020)
Authors: Ahluwalia M, Peereboom D, Rauf Y, et al.
Read article